Answer
Glofitamab has two binding sites for CD20 on B cells and one binding site for CD3 in the T-cell receptor complex on T cells.
Sources for this answer
- Columvi 2.5 mg, 10 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 6Document updated
Sources checked